World Law Group’s Cannabis Group consists of member firm lawyers with expertise in the legal issues relevant to industry participants. Our expertise includes much more than compliance-related activities (licensing, product specific taxes, regulatory compliance, etc.). For example, our expertise is critical when advising clients about the issues most relevant to the industry, such as banking, protection of IP, cross-border investments, specialized financing issues, particularized tax rules and the unique challenges in the M&A market. These issues are often complicated by differences between local and federal laws, their overlap with international treaties, and differences in cultural and political acceptance for the industry’s products. The group’s goal is to be able to tap each other’s local knowledge to provide relevant and seamless client advice, especially in cross-border investments (including research arrangements), financing and import/export challenges, in this fast-growing market.
For more information, contact this group's leaders or Hanna Shea, WLG’s Manager, Communication & Network Development.
Since the latest update from us in September 2019, there has been no legislative changes within the jurisdiction. However, there has been a great deal of debate about the four-year medicinal cannabis pilot programme, which was introduced in Denmark in 2018.
The Washington State Legislature’s 2020 regular session is proceeding, and we will be covering new bills as they develop.
The Democratic-led House of Representatives recently took another step forward in advancing legislation to support therapidly growing cannabis industry in the United States.
Presentation from the WLG Cannabis Group on The Vaping Health Controversy.